Higher CYP2E1 Activity Correlates with Hepatocarcinogenesis Induced by Diethylnitrosamine

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2018-05-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1124/jpet.117.245555PMID 29467309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The end of almost 10 years of negative RCTs in advanced hepatocellular carcinoma.

  2017cited by this paper
• IL‐6 trans‐signaling is essential for the development of hepatocellular carcinoma in mice

  2017cited by this paper
• The Role of CYP2E1 in the Drug Metabolism or Bioactivation in the Brain

  2017cited by this paper
• Gene polymorphisms and contents of cytochrome P450s have only limited effects on metabolic activities in human liver microsomes.

  2016cited by this paper
• Selective Time- and NADPH-Dependent Inhibition of Human CYP2E1 by Clomethiazole

  2016cited by this paper
• Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma

  2016cited by this paper
• Changes in cytochrome P450s-mediated drug clearance in patients with hepatocellular carcinoma in vitro and in vivo: a bottom-up approach

  2016cited by this paper
• Interleukin‐1β/Iinterleukin‐1 receptor‐associated kinase 1 inflammatory signaling contributes to persistent Gankyrin activation during hepatocarcinogenesis

  2015cited by this paper
• Chemopreventive Effects of Korean Red Ginseng Extract on Rat Hepatocarcinogenesis

  2015cited by this paper
• The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma

  2015cited by this paper
• Formation and mitigation of N-nitrosamines in nitrite preserved cooked sausages.

  2015cited by this paper
• Content and activity of human liver microsomal protein and prediction of individual hepatic clearance in vivo

  2015cited by this paper
• Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas

  2015cited by this paper
• Inhibition of cytochrome P4502E1 by chlormethiazole attenuated acute ethanol-induced fatty liver.

  2014cited by this paper
• Cytochrome P450 2E1 gene polymorphism and alcohol drinking on the risk of hepatocellular carcinoma: a meta-analysis

  2014cited by this paper
• CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis.

  2014cited by this paper
• Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.

  2013cited by this paper
• Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

  2013cited by this paper
• Garlic Oil Attenuated Nitrosodiethylamine-Induced Hepatocarcinogenesis by Modulating the Metabolic Activation and Detoxification Enzymes

  2013cited by this paper
• CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis.

  2013cited by this paper
• Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis.

  2012cited by this paper
• RB and p53 cooperate to prevent liver tumorigenesis in response to tissue damage.

  2011cited by this paper
• A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma.

  2011cited by this paper
• CYP2E1 and risk of chemically mediated cancers

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• Association between CYP2E1 genetic polymorphisms and lung cancer risk: a meta-analysis.

  2010cited by this paper
• Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer.

  2009cited by this paper
• Trends in mortality from hepatocellular carcinoma in Europe, 1980‐2004

  2008cited by this paper
• Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo.

  2007influential reference
• Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

  2007cited by this paper
• Liver disease selectively modulates cytochrome P450–mediated metabolism

  2006influential reference
• Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1.

  2005cited by this paper
• Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate.

  2003influential reference
• The use of gene knockout mice to unravel the mechanisms of toxicity and chemical carcinogenesis.

  2001cited by this paper
• DNA damage induced by red food dyes orally administered to pregnant and male mice.

  2001cited by this paper
• Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase.

  2000cited by this paper
• N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation.

  1996cited by this paper
• Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes.

  1996cited by this paper
• Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC.

  1995cited by this paper
• Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma.

  1995cited by this paper
• Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease

  1995cited by this paper
• Chronic hepatitis: morphology and nomenclature.

  1994cited by this paper
• High variability of nitrosamine metabolism among individuals: Role of cytochromes P450 2A6 and 2E1 in the dealkylation of N‐nitrosodimethylamine and N‐nitrosodiethylamine in mice and humans

  1993cited by this paper
• Participation of rat liver cytochrome P450 2E1 in the activation of N-nitrosodimethylamine and N-nitrosodiethylamine to products genotoxic in an acetyltransferase-overexpressing Salmonella typhimurium strain (NM2009).

  1992cited by this paper
• Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects.

  1991cited by this paper
• Roles of cytochrome P450IIE1 in the dealkylation and denitrosation of N-nitrosodimethylamine and N-nitrosodiethylamine in rat liver microsomes.

  1990cited by this paper
• Monoclonal antibodies to ethanol-induced rat liver cytochrome P-450 that metabolizes aniline and nitrosamines.

  1987cited by this paper
• Hepatocellular carcinoma.

  1986cited by this paper
• Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice.

  1986cited by this paper
• Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions.

  1985cited by this paper
• Relevance of nitrosamines to human cancer.

  1984influential reference
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• 4-Methyl-5-Acetylthiazole (Q11), a novel CYP2E1 inhibitor, has a protective effect on the hepatotoxicity induced by acetaminophen.

  2026cites this paper
• Integrating multi-omics data and machine learning to identify endocrine disrupting chemicals targeting key ccRCC-related genes

  2025cites this paper
• Identification of Cytochrome P450 2E1 as a Novel Target in Neuroinflammation and Development of Its Inhibitor Q11 as a Treatment Strategy.

  2025cites this paper
• Decoding the hepatic fibrosis-hepatocellular carcinoma axis: from mechanisms to therapeutic opportunities

  2025cites this paper
• Astragalus Injection Modulates the Pharmacokinetics of Doxorubicin and CYP450 Enzymes.

  2025cites this paper
• Discovery of a CYP2E1 inhibitor and its therapeutic potential in severe acute pancreatitis.

  2025cites this paper
• Effects of the Polar Fraction of Lophocereus schottii on Gene Expression and Hepatocyte Proliferation in a Wistar Rat Model of Hepatocellular Carcinoma

  2025cites this paper
• Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review

  2024cites this paper
• Q11, a CYP2E1 inhibitor, exerts anti-hepatocellular carcinoma effect by inhibiting M2 macrophage polarization

  2024cites this paper
• Cytochrome P450 2E1 inhibitor Q11 is effective on hepatocellular carcinoma by promoting peritumor neutrophil chemotaxis.

  2024cites this paper
• Discovery of CYP2E1 as a novel target in rheumatoid arthritis and validation by a new specific CYP2E1 inhibitor.

  2024cites this paper
• Identification of Cytochrome P450 2E1 as a Novel Target in Glioma and Development of Its Inhibitor as an Anti‐Tumor Agent

  2023cites this paper
• Past, present, and future of chemically induced hepatocarcinogenesis rodent models: Perspectives concerning classic and new cancer hallmarks.

  2023cites this paper
• The CYP2E1 inhibitor Q11 ameliorates LPS-induced sepsis in mice by suppressing oxidative stress and NLRP3 activation.

  2023cites this paper
• Hepatic Effect of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside，the Signature Component of Traditional Chinese Medicine Heshouwu: Advances and Prospects.

  2023cites this paper
• An iron-deficient diet prevents alcohol- or diethylnitrosamine-induced acute hepatotoxicity in mice by inhibiting ferroptosis

  2022cites this paper
• Stat4 rs7574865 polymorphism promotes the occurrence and progression of hepatocellular carcinoma via the Stat4/CYP2E1/FGL2 pathway

  2022cites this paper
• The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomics

  2022cites this paper
• The proteomic characterization of the peritumor microenvironment in human hepatocellular carcinoma

  2022cites this paper
• Effects of Gene Polymorphisms, Metabolic Activity, and Content of Alcohol Dehydrogenase and Acetaldehyde Dehydrogenases on Prognosis of Hepatocellular Carcinoma Patients.

  2022cites this paper
• The effect of aging on the repeated-dose liver micronucleus assay using diethylnitrosamine

  2022cites this paper
• Allelic variations in alcohol metabolism genes (ADH1B, ADH1C, CYP2E1) and alcohol use disorder (AUD) in northeastern Brazil

  2022cites this paper
• Ferulic acid prevents aflatoxin B1-induced liver injury in rats via inhibiting cytochrome P450 enzyme, activating Nrf2/GST pathway and regulating mitochondrial pathway.

  2021cites this paper
• Use of proteomics to identify mechanisms of hepatocellular carcinoma with the CYP2D6*10 polymorphism and identification of ANGPTL6 as a new diagnostic and prognostic biomarker

  2021cites this paper
• In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling

  2021cites this paper
• Standardization of diethylnitrosamine-induced hepatocellular carcinoma rat model with time based molecular assessment.

  2021cites this paper
• CD276 Promotes Vasculogenic Mimicry Formation in Hepatocellular Carcinoma via the PI3K/AKT/MMPs Pathway

  2020cites this paper
• Chondroitin-modified lipid nanoparticles target the Golgi to degrade extracellular matrix for liver cancer management.

  2020cites this paper
• Ascorbic acid prevents N-nitrosodiethylamine-induced hepatic injury and hepatocarcinogenesis in Akr1a-knockout mice.

  2020cites this paper
• 2,3,5,4'-Tetrahydroxystilbene-2-O-β-d-glucoside alleviated the acute hepatotoxicity and DNA damage in diethylnitrosamine-contaminated mice.

  2020cites this paper
• Metabolism of N-nitrosodimethylamine, methylation of macromolecules, and development of hepatic fibrosis in rodent models

  2020cites this paper
• OTT_A_271891 11485..11498

  2020cites this paper
• Several Biomolecular Parameters as Prognostic, Therapeutic and Preventive Factors of Nasopharyngeal Carcinoma

  2020cites this paper
• Involvement of single nucleotide polymorphisms in acute lymphoblastic leukemia susceptibility

  2020cites this paper
• Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis

  2019cites this paper
• From Genotype to Phenotype: Content and Activities of Cytochromes P450 2A6 in Human Liver In Vitro and Predicted In Vivo

  2019cites this paper
• Dendrimer-conjugated podophyllotoxin suppresses DENA-induced HCC progression by modulation of inflammatory and fibrogenic factors.

  2019cites this paper
• Molecular Carcinogenesis

  2019cites this paper
• From hepatofibrosis to hepatocarcinogenesis: Higher cytochrome P450 2E1 activity is a potential risk factor

  2018cites this paper
• Effect of P450 Oxidoreductase Polymorphisms on the Metabolic Activities of Ten Cytochrome P450s Varied by Polymorphic CYP Genotypes in Human Liver Microsomes

  2018cites this paper
• Adverse Outcome Pathway External Review Report

  2018cites this paper